Department of Obstetrics and Gynaecology, Epsom & St Helier University Hospitals NHS Trust, London, UK.
Laboratory of Experimental Surgery and Surgical Research N.S. Christeas, University of Athens, Medical School, Athens, Greece.
BJOG. 2019 Nov;126(12):1417-1422. doi: 10.1111/1471-0528.15891. Epub 2019 Sep 18.
Several meta-analyses have identified methodological limitations in female stress urinary incontinence (SUI) trials, precluding the synthesis of primary studies and high-quality evidence.
Evaluation of outcome measure selection and outcome reporting in randomised controlled trials (RCTs) on surgery for SUI.
Systematic review of RCTs identified from bibliographical databases, including Medline, Cochrane, and EMBASE.
Randomised controlled trials evaluating the efficacy and safety of surgical interventions for the management of female SUI.
Two researchers independently assessed the included studies and documented outcomes.
Overall, 108 studies were identified that included 422 reported outcomes and 119 outcome measures. The three most common outcomes were cure rates (87 studies), quality of life (85 studies), and overactive bladder (78 studies). The median methodological quality rating was 3 (range 0-3) and the outcome reporting quality rating was 3 (range 0-5). Multinomial logistic regression analysis revealed that the methodological quality and use of validated questionnaire were significant predictors of the quality of outcome reporting (β = 0.538, P < 0.001; β = 0.218, P = 0.011, respectively).
Outcome reporting in SUI trials is highly variable. Until a core outcome set is developed and implemented, we propose an interim use of three commonly reported outcomes in each domain (treatment success rate - complete cure, partial improvement, or failure of response; urodynamic evaluation outcomes - overactive bladder (OAB), voiding dysfunction, and urodynamic stress incontinence; patient-reported outcomes - quality of life, sexual dysfunction, and patient satisfaction) with the use of validated questionnaires for patient-reported outcomes and subjective success rates. Complications should be also explicitly and comprehensively reported using validated outcome measures.
There is significant variation in outcome reporting in SUI trials. Our systematic review findings aim to form the basis for the development of a core outcome set.
几项荟萃分析已经确定了女性压力性尿失禁(SUI)试验中的方法学局限性,使得无法综合主要研究和高质量证据。
评估 SUI 手术随机对照试验(RCT)中结局测量选择和结局报告的情况。
系统检索了来自文献数据库的 RCT,包括 Medline、Cochrane 和 EMBASE。
评估手术干预女性 SUI 管理疗效和安全性的随机对照试验。
两位研究人员独立评估了纳入的研究并记录了结果。
共确定了 108 项研究,其中包括 422 项报告的结局和 119 项结局指标。最常见的三个结局是治愈率(87 项研究)、生活质量(85 项研究)和膀胱过度活动症(78 项研究)。方法学质量评分中位数为 3(范围 0-3),结局报告质量评分为 3(范围 0-5)。多项逻辑回归分析显示,方法学质量和使用验证问卷是结局报告质量的显著预测因素(β=0.538,P<0.001;β=0.218,P=0.011)。
SUI 试验中的结局报告高度可变。在制定和实施核心结局集之前,我们建议在每个领域使用三个常见的报告结局(治疗成功率-完全治愈、部分改善或无反应;尿动力学评估结局-膀胱过度活动症(OAB)、排尿功能障碍和尿动力学压力性尿失禁;患者报告结局-生活质量、性功能障碍和患者满意度),并使用验证后的问卷报告患者报告结局和主观成功率。还应使用验证后的结局测量方法明确和全面地报告并发症。
SUI 试验中的结局报告存在显著差异。我们的系统评价结果旨在为制定核心结局集奠定基础。